FR2352533A1 - Procede de detection du cancer - Google Patents

Procede de detection du cancer

Info

Publication number
FR2352533A1
FR2352533A1 FR7715965A FR7715965A FR2352533A1 FR 2352533 A1 FR2352533 A1 FR 2352533A1 FR 7715965 A FR7715965 A FR 7715965A FR 7715965 A FR7715965 A FR 7715965A FR 2352533 A1 FR2352533 A1 FR 2352533A1
Authority
FR
France
Prior art keywords
detection method
cancer detection
cancer
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7715965A
Other languages
English (en)
Other versions
FR2352533B1 (fr
Inventor
Jose Ramon Marti
David Marshall Parks Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2352533A1 publication Critical patent/FR2352533A1/fr
Application granted granted Critical
Publication of FR2352533B1 publication Critical patent/FR2352533B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7715965A 1976-05-27 1977-05-25 Procede de detection du cancer Granted FR2352533A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69045476A 1976-05-27 1976-05-27

Publications (2)

Publication Number Publication Date
FR2352533A1 true FR2352533A1 (fr) 1977-12-23
FR2352533B1 FR2352533B1 (fr) 1980-06-13

Family

ID=24772522

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7715965A Granted FR2352533A1 (fr) 1976-05-27 1977-05-25 Procede de detection du cancer

Country Status (18)

Country Link
JP (1) JPS52145517A (fr)
AT (1) AT357690B (fr)
AU (1) AU506539B2 (fr)
BE (1) BE855063A (fr)
DE (1) DE2724114A1 (fr)
DK (1) DK233277A (fr)
ES (1) ES459164A1 (fr)
FI (1) FI771646A (fr)
FR (1) FR2352533A1 (fr)
GB (1) GB1520208A (fr)
IE (1) IE45284B1 (fr)
IL (1) IL52133A0 (fr)
LU (1) LU77413A1 (fr)
NL (1) NL7705873A (fr)
NO (1) NO771860L (fr)
NZ (1) NZ184159A (fr)
SE (1) SE7706203L (fr)
ZA (1) ZA773026B (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USB554039I5 (fr) * 1975-02-28 1976-02-24
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USB554039I5 (fr) * 1975-02-28 1976-02-24
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma

Also Published As

Publication number Publication date
AT357690B (de) 1980-07-25
FR2352533B1 (fr) 1980-06-13
ZA773026B (en) 1978-04-26
LU77413A1 (fr) 1978-06-26
BE855063A (fr) 1977-11-28
SE7706203L (sv) 1977-11-28
IE45284B1 (en) 1982-07-28
FI771646A (fr) 1977-11-28
ES459164A1 (es) 1978-04-16
IE45284L (en) 1977-11-27
NL7705873A (nl) 1977-11-29
AU2534177A (en) 1978-11-23
JPS52145517A (en) 1977-12-03
NO771860L (no) 1977-11-29
NZ184159A (en) 1979-03-28
IL52133A0 (en) 1977-07-31
DK233277A (da) 1977-11-28
AU506539B2 (en) 1980-01-10
ATA376977A (de) 1979-12-15
DE2724114A1 (de) 1977-12-15
GB1520208A (en) 1978-08-02

Similar Documents

Publication Publication Date Title
BE866875A (nl) Detectiestelsel
BE855273A (fr) Procede de preparation de polyurethannes
BE857854A (fr) Procede de preparation de polyurethanne-urees
NL7801270A (nl) Magnetisch detectiestelsel.
IT1074352B (it) Sistema rivelatore di difetti
IT1203179B (it) Sistema elaboratore dei segnali
RO75807A (fr) Procede de microencapsulage
NO782848L (no) Detekteringsanlegg.
BE851742A (fr) Procede de soudage
IT1062400B (it) Apparecchio per la rivelazione di veicoli
BE856313A (fr) Procede de preparation de benzothiazoles
BE856201A (fr) Procede de revetement
AR227609A1 (es) Aparato de empenachar
NL7805524A (nl) Detectiestelsel.
SE447761B (sv) Forfarande for bestemning av metadon
DK421977A (da) Immunologisk paavisningsmetode
BR7706180A (pt) Sistema de floculacao eletrostastica
FR2333393A1 (fr) Procede et disposition de detection de porteuse
BE853162A (fr) Procede de preparation de chloromethylsilanes
BR7701372A (pt) Dispositivo de deteccao de radiacao
BE854691A (fr) Procede dermatologique
BE860699A (fr) Procede de preparation de gamma-pyrones
BE858519R (fr) Procede de desulfuration
SE7707753L (sv) Avkenningselement for en elektrokemisk syre-metapparat
BE859358A (fr) Procede de chloration du meta-aryloxytoluene

Legal Events

Date Code Title Description
ST Notification of lapse